Table 3

Medication prescribed as initial treatment and average time in weeks from diagnosis until start in patients in whom MTX, leflunomide, sulfasalazine or injectable gold was NOT started as first DMARD

Patients (n total=78)
(N, %)
Average time to start per therapy (median, IQR)
Hydroxychloroquine (±NSAID)12 (15)0 (0–0)
Parental corticosteroid (±HCQ)28 (36)0 (0–0)
Oral corticosteroid (±HCQ)28 (36)0 (0–3)
NSAID/analgetics3 (4)0 (0–0)
Ciclosporin1 (1)0 (0–0)
Biological DMARD6 (8)64 (4–245)
  • DMARD, disease-modifying antirheumatic drug; HCQ, hydroxychloroquine; NSAID, non-steroidal anti-inflammatory drug.